Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$12,480,847
+$3,201,905 QoQ
Shares Held
49,143
+29.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#980
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Jun 30, 2026CallValue
$50,794
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026B. Riley Wealth Advisors, Inc. holds $62,126,199 across 15 Drug Manufacturers - General names. JNJ ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,302 | $26,749,690 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
49,143 | $12,480,847 | |
| 3 | ABBV |
AbbVie Inc.
|
32,220 | $8,107,840 | |
| 4 | MRK |
Merck & Co., Inc.
|
29,226 | $3,755,541 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
56,350 | $3,246,887 | |
| 6 | PFE |
Pfizer Inc
|
90,498 | $2,179,191 | |
| 7 | AMGN |
Amgen Inc
|
3,654 | $1,323,186 | |
| 8 | AZN |
Astrazeneca PLC
|
4,594 | $871,114 |
All Filings in JNJ
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,794 | 200 | Call | Sole | 2026-07-14 | |
| 2026-06-30 | $12,480,847 | 49,143 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $9,278,942 | 37,960 | Shares | Sole | 2026-04-27 | |
| 2026-03-31 | $48,498 | 20,000 | Call | Sole | 2026-04-27 | |
| 2025-12-31 | $41,390 | 200 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $8,149,277 | 39,378 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $55,626 | 30,000 | Call | Sole | 2025-10-31 | |
| 2025-09-30 | $7,326,685 | 39,514 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $45,825 | 300 | Call | Sole | 2025-08-19 | |
| 2025-06-30 | $7,437,550 | 48,691 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $599,179 | 3,613 | Call | Sole | 2026-08-28 | |
| 2025-03-31 | $16,457,132 | 99,235 | Shares | Sole | 2026-08-28 | |
| 2024-12-31 | $12,246,276 | 84,679 | Shares | Sole | 2025-02-25 | |
| 2024-09-30 | $15,911,536 | 98,183 | Shares | Sole | 2024-12-13 | |
| 2024-06-30 | $17,137,260 | 117,250 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $23,489,000 | 148,486 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $22,207,550 | 141,684 | Shares | Sole | 2024-03-15 | |
| 2023-09-30 | $23,126,694 | 148,486 | Shares | Sole | 2023-12-01 | |
| 2023-06-30 | $24,712,632 | 149,303 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $24,594,470 | 158,674 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $29,556,724 | 167,318 | Shares | Sole | 2023-03-15 | |
| 2022-09-30 | $26,302,918 | 161,012 | Shares | Other | 2022-11-22 | |
| 2022-06-30 | $18,596,122 | 104,761 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $19,558,391 | 110,356 | Shares | Other | 2022-05-02 | |
| 2021-12-31 | $19,456,987 | 113,737 | Shares | Other | 2022-01-28 | |
| 2021-09-30 | $18,536,485 | 114,777 | Shares | Other | 2021-11-16 | |
| 2021-06-30 | $18,550,712 | 112,606 | Shares | Other | 2021-08-10 | |
| 2021-03-31 | $17,628,507 | 107,262 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $10,988,268 | 69,820 | Shares | Other | 2021-02-04 | |
| 2020-09-30 | $13,809,361 | 92,755 | Shares | Other | 2020-11-09 | |
| 2020-06-30 | $10,789,130 | 76,720 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $10,155,885 | 77,449 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||